WST: SEC Form 8-K filed by West Pharmaceutical Services Inc.
Stocks in this Quantisnow insightHealth Care
Full content unavailable. See the original source below.
Historical context for WST
Across the 28 sessions after earlier WST headlines, the stock closed higher 12 times and lower 16 times, with a median move of 2.0% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | WST | SPY |
|---|---|---|---|
| Oct 20, 2026 | West Declares Quarterly Dividend | +1.3% | +0.3% |
| Oct 8, 2026 | West to Host Third-Quarter 2026 Conference Call | -0.9% | -0.4% |
| Oct 5, 2026 | West to Highlight Industry Leadership in Packaging and Containment at CPHI Worldwide | +3.2% | +0.7% |
| Sep 22, 2026 | West Pharm upgraded by Morgan Stanley with a new price target | +2.6% | -0.0% |
| Sep 9, 2026 | UBS resumed coverage on West Pharm with a new price target | -0.2% | -0.5% |
| Aug 27, 2026 | West to Participate in Upcoming Investor Conferences | -1.1% | +0.7% |
Quantisnow market dataNYSE
WST
West Pharmaceutical Services Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
Get push alerts for WST
Full WST profile on Quantisnow Follow WST and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time